Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hsiu-Mien Wang"'
Publikováno v:
Asian Journal of Transfusion Science, Vol 11, Iss 2, Pp 209-211 (2017)
Daratumumab is a monoclonal immunoglobulin against CD38 and has been approved for treating patients with refractory multiple myeloma. The presence of daratumumab in the sera can interfere with pretransfusion testing due to the weakly expression of CD
Externí odkaz:
https://doaj.org/article/4683b533af0640d1bfa6294de4f3c3de
Publikováno v:
Asian Journal of Transfusion Science, Vol 11, Iss 2, Pp 209-211 (2017)
Asian Journal of Transfusion Science
Asian Journal of Transfusion Science
Daratumumab is a monoclonal immunoglobulin against CD38 and has been approved for treating patients with refractory multiple myeloma. The presence of daratumumab in the sera can interfere with pretransfusion testing due to the weakly expression of CD